Allarity Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Allarity Therapeutics, Inc. (ALLR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 25.00 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-03-30
- Allarity Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- Allarity Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 0.00 shares.
- Allarity Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-12-31 was 7.00 shares.
- Allarity Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-09-30 was -6.00 shares, a 154.55% decline year-over-year.
- Allarity Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 25.00K shares, a 277677.78% increase from fiscal 2024.
- Allarity Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 9.00 shares, a 800.00% increase from fiscal 2023.
- Allarity Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 1.00 shares, a 100.00% decline from fiscal 2022.
- Allarity Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 544.04K shares, a 1087.73% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-30 | 25.00K shares 10-K · filed 2026-03-30 | |||
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 25.00K shares 10-Q · filed 2025-11-14 | ||||
| 2025-06-30 | 25.00K shares 10-Q · filed 2025-08-15 | |||||
| 2024-12-31 | 7.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 1.00 shares derived: sum of 2 quarters · filed 2026-03-30 | 4.00 shares derived: sum of 3 quarters · filed 2026-03-30 | 9.00 shares 10-K · filed 2026-03-30 | ||
| 2024-09-30 | -6.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -3.00 shares derived: sum of 2 quarters · filed 2024-11-14 | 2.00 shares 10-Q · filed 2024-11-14 | -79.00 shares derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2024-06-30 | 3.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | 8.00 shares 10-Q · filed 2024-08-05 | -73.00 shares derived: sum of 3 quarters · filed 2025-03-31 | -62.00 shares derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2024-03-31 | 5.00 shares 10-Q · filed 2024-05-14 | -76.00 shares derived: sum of 2 quarters · filed 2025-03-31 | -65.00 shares derived: sum of 3 quarters · filed 2025-03-31 | -1.76K shares derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2023-12-31 | -81.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -70.00 shares derived: sum of 2 quarters · filed 2025-03-31 | -1.76K shares derived: sum of 3 quarters · filed 2025-03-31 | 1.00 shares 10-K · filed 2025-03-31 | 101.00 shares 10-K · filed 2024-03-08 | |
| 2023-09-30 | 11.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -1.68K shares derived: sum of 2 quarters · filed 2023-11-14 | 82.00 shares 10-Q · filed 2023-11-14 | 82.00 shares derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2023-06-30 | -1.69K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 71.00 shares 10-Q · filed 2023-08-14 | 71.00 shares derived: sum of 3 quarters · filed 2023-08-14 | |||
| 2023-03-31 | 1.76K shares 10-Q · filed 2023-05-11 | 1.76K shares derived: sum of 2 quarters · filed 2023-05-11 | ||||
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | 544.04K shares 10-K · filed 2023-03-13 | ||||
| 2022-09-30 | 544.04K shares 10-Q · filed 2022-11-14 | |||||
| 2021-12-31 | 45.80K shares 10-K · filed 2022-05-17 | |||||
| 2021-09-30 | 40.60K shares 10-Q/A · filed 2022-05-17 | 2.03M shares 10-Q · filed 2021-11-23 | ||||
| 2020-12-31 | 27.02K shares 10-Q/A · filed 2022-05-17 | 1.35M shares 10-Q · filed 2021-11-23 | 27.02K shares 10-K · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |